Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Alembic Pharmaceuticals has informed that the exchange that the share certificate(s) of the Company has been reported as lost/ misplaced and the legal heir(s) of the registered shareholder(s) of such lost share certificate(s) have requested the Company for issue of duplicate share certificate(s) for the purpose of claiming those shares from the Investor Education and Protection Fund (IEPF).
The above information is a part of company’s filings submitted to BSE.
